Biogen, Inc. (BIIB)
218.11
+1.33
(+0.61%)
USD |
NASDAQ |
Aug 24, 16:00
218.11
0.00 (0.00%)
After-Hours: 20:00
Biogen EPS Diluted (Quarterly) : 0.6557 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.6557 |
| March 31, 2026 | 2.153 |
| December 31, 2025 | -0.3333 |
| September 30, 2025 | 3.171 |
| June 30, 2025 | 4.327 |
| March 31, 2025 | 1.640 |
| December 31, 2024 | 1.826 |
| September 30, 2024 | 2.659 |
| June 30, 2024 | 4.00 |
| March 31, 2024 | 2.696 |
| December 31, 2023 | 1.714 |
| September 30, 2023 | -0.4703 |
| June 30, 2023 | 4.066 |
| March 31, 2023 | 2.672 |
| December 31, 2022 | 3.791 |
| September 30, 2022 | 7.836 |
| June 30, 2022 | 7.237 |
| March 31, 2022 | 2.058 |
| December 31, 2021 | 2.496 |
| September 30, 2021 | 2.215 |
| June 30, 2021 | 2.988 |
| March 31, 2021 | 2.693 |
| December 31, 2020 | 2.324 |
| September 30, 2020 | 4.462 |
| June 30, 2020 | 9.584 |
| Date | Value |
|---|---|
| March 31, 2020 | 8.083 |
| December 31, 2019 | 8.079 |
| September 30, 2019 | 8.392 |
| June 30, 2019 | 7.847 |
| March 31, 2019 | 7.151 |
| December 31, 2018 | 4.73 |
| September 30, 2018 | 7.15 |
| June 30, 2018 | 4.18 |
| March 31, 2018 | 5.54 |
| December 31, 2017 | -1.41 |
| September 30, 2017 | 5.79 |
| June 30, 2017 | 4.07 |
| March 31, 2017 | 3.46 |
| December 31, 2016 | 2.99 |
| September 30, 2016 | 4.71 |
| June 30, 2016 | 4.785 |
| March 31, 2016 | 4.43 |
| December 31, 2015 | 3.77 |
| September 30, 2015 | 4.15 |
| June 30, 2015 | 3.93 |
| March 31, 2015 | 3.49 |
| December 31, 2014 | 3.74 |
| September 30, 2014 | 3.62 |
| June 30, 2014 | 3.01 |
| March 31, 2014 | 2.02 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ionis Pharmaceuticals, Inc. | -0.6931 |
| AbbVie, Inc. | 2.033 |
| Gilead Sciences, Inc. | -8.444 |
| Vertex Pharmaceuticals, Inc. | 4.310 |
| Amgen, Inc. | 4.366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 97.50M |
| Revenue (Quarterly) | 2.622B |
| Total Expenses (Quarterly) | 2.525B |
| Enterprise Value | 39.09B |
| Gross Profit Margin (Quarterly) | 61.37% |
| Profit Margin (Quarterly) | 3.72% |
| Earnings Yield | 2.59% |
| Operating Earnings Yield | 5.85% |
| Normalized Earnings Yield | 4.189 |